Universal Health Services, Inc. UHS
190.49 USD +13.36 (+7.54%)
Nov 4, 2026, 11:11 AM EST
185.47 Day range 190.98
141.17 52-week range 244.18
- YTD
- -12.63%
- 1 year
- -15.03%
Analyst view
Consensus: buy
Buy
Price target (mean) 192.41 +1.0% upside
Now 190.49
- Target (low)
- 156.00
- Target (mean)
- 192.41
- Target (high)
- 250.00
Ratings (0m) 20 6 buy · 13 hold · 1 sell
- Strong buy0
- Buy6
- Hold13
- Sell0
- Strong sell1
Recommendation trend
- This month 20
- 1 month ago 20
- 2 months ago 20
- 3 months ago 20
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 5.64 | 4.90 – 5.88 | 5.88 | -4.1% | 4.75B | +6.0% | 15 |
| Next quarter | 5.65 | 4.87 – 6.41 | 5.62 | +0.5% | 4.73B | +5.2% | 9 |
| Current year | 22.47 | 21.76 – 22.92 | 21.74 | +3.4% | 18.61B | +7.2% | 14 |
| Next year | 23.01 | 21.06 – 24.30 | 22.47 | +2.4% | 19.51B | +4.8% | 16 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 2, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Oct 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Oct 29, 2026 | Baird | Maintained | Neutral | Neutral |
| Sep 18, 2026 | Leerink Partners | Maintained | Outperform | Outperform |
| Aug 20, 2026 | RBC Capital | Reiterated | Sector Perform | Sector Perform |
| Aug 3, 2026 | RBC Capital | Maintained | Sector Perform | Sector Perform |
| Jul 30, 2026 | Goldman Sachs | Maintained | Neutral | Neutral |
| Jul 29, 2026 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Jul 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 29, 2026 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Jul 29, 2026 | Baird | Maintained | Neutral | Neutral |
| Jul 28, 2026 | Cantor Fitzgerald | Reiterated | Neutral | Neutral |
| Jul 28, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 20, 2026 | Guggenheim | Maintained | Buy | Buy |
| Jul 13, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Jul 8, 2026 | Barclays | Downgrade | Overweight | Equal-Weight |
| Jun 22, 2026 | TD Cowen | Maintained | Buy | Buy |
| Apr 30, 2026 | UBS | Maintained | Buy | Buy |
| Apr 29, 2026 | TD Cowen | Maintained | Buy | Buy |
| Apr 29, 2026 | RBC Capital | Maintained | Sector Performer | Sector Perform |
| Apr 29, 2026 | Guggenheim | Maintained | Buy | Buy |
| Apr 29, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Apr 29, 2026 | Baird | Maintained | Neutral | Neutral |
| Apr 28, 2026 | Barclays | Maintained | Overweight | Overweight |
| Mar 2, 2026 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Feb 27, 2026 | Cantor Fitzgerald | Maintained | Neutral | Neutral |
| Feb 26, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 22, 2026 | Barclays | Maintained | Overweight | Overweight |
| Jan 7, 2026 | TD Cowen | Maintained | Buy | Buy |
| Jan 7, 2026 | Wells Fargo | Downgrade | Overweight | Equal-Weight |